These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 1710741

  • 1. Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus.
    Alberti KG, Jones IR, Laker MF, Swai AB, Taylor R.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S21-4; discussion S24-5. PubMed ID: 1710741
    [Abstract] [Full Text] [Related]

  • 2. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.
    Jones IR, Swai A, Taylor R, Miller M, Laker MF, Alberti KG.
    Diabetes Care; 1990 Aug; 13(8):855-63. PubMed ID: 2209320
    [Abstract] [Full Text] [Related]

  • 3. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients.
    Taniguchi A, Fukushima M, Sakai M, Tokuyama K, Nagata I, Fukunaga A, Kishimoto H, Doi K, Yamashita Y, Matsuura T, Kitatani N, Okumura T, Nagasaka S, Nakaishi S, Nakai Y.
    Metabolism; 2001 Apr; 50(4):477-80. PubMed ID: 11288046
    [Abstract] [Full Text] [Related]

  • 4. The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
    Mathur S, Barradas MA, Mikhailidis DP, Dandona P.
    Diabetes Res; 1990 Jul; 14(3):133-8. PubMed ID: 2132185
    [Abstract] [Full Text] [Related]

  • 5. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
    Elkeles RS.
    Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
    [Abstract] [Full Text] [Related]

  • 6. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB, Johnston P, Varasteh BB, Chen YD, Reaven GM.
    Diabete Metab; 1991 May; 17(5):483-9. PubMed ID: 1752350
    [Abstract] [Full Text] [Related]

  • 7. Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic control.
    Durrington PN, Winocour PH, Bhatnagar D.
    J Cardiovasc Pharmacol; 1990 May; 16 Suppl 9():S30-4. PubMed ID: 1710743
    [Abstract] [Full Text] [Related]

  • 8. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y.
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [Abstract] [Full Text] [Related]

  • 9. Bezafibrate retard in type II diabetic patients: effects on hemostasis and glucose homeostasis.
    Mikhailidis DP, Mathur S, Barradas MA, Dandona P.
    J Cardiovasc Pharmacol; 1990 Aug; 16 Suppl 9():platelet inhib/pd/ad/ae. PubMed ID: 1710742
    [Abstract] [Full Text] [Related]

  • 10. C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
    Vessby B, Boberg M, Hellsing K, Lithell H, Berne C.
    Diabetes Res; 1989 Nov; 12(3):109-16. PubMed ID: 2699585
    [Abstract] [Full Text] [Related]

  • 11. Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.
    Lampman RM, Schteingart DE.
    Med Sci Sports Exerc; 1991 Jun; 23(6):703-12. PubMed ID: 1886478
    [Abstract] [Full Text] [Related]

  • 12. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J, Vandenberg M, Grunberger G.
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [Abstract] [Full Text] [Related]

  • 13. Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects.
    Tremblay-Mercier J, Tessier D, Plourde M, Fortier M, Lorrain D, Cunnane SC.
    J Pharmacol Exp Ther; 2010 Jul; 334(1):341-6. PubMed ID: 20404010
    [Abstract] [Full Text] [Related]

  • 14. [Improvement in diabetes control by treatment with bezafibrate].
    Rüth E, Vollmar J.
    Dtsch Med Wochenschr; 1982 Oct 01; 107(39):1470-3. PubMed ID: 6749468
    [Abstract] [Full Text] [Related]

  • 15. Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes.
    Riccardi G, Genovese S, Saldalamacchia G, Patti L, Marotta G, Postiglione A, Rivellese A, Capaldo B, Mancini M.
    Atherosclerosis; 1989 Feb 01; 75(2-3):175-81. PubMed ID: 2653325
    [Abstract] [Full Text] [Related]

  • 16. Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
    Jeck T, Riesen WF, Keller U.
    Diabet Med; 1997 Jul 01; 14(7):564-70. PubMed ID: 9223394
    [Abstract] [Full Text] [Related]

  • 17. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
    Wahl P, Hasslacher C, Lang PD, Vollmar J.
    Dtsch Med Wochenschr; 1978 Aug 04; 103(31):1233-7. PubMed ID: 668570
    [Abstract] [Full Text] [Related]

  • 18. Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention.
    Seviour PW, Teal TK, Richmond W, Elkeles RS.
    Diabet Med; 1988 Mar 04; 5(2):166-71. PubMed ID: 2964984
    [Abstract] [Full Text] [Related]

  • 19. Monocyte-suppressing effect of bezafibrate but not omega-3 fatty acids in patients with isolated hypertriglyceridaemia.
    Krysiak R, Gdula-Dymek A, Okopien B.
    Basic Clin Pharmacol Toxicol; 2011 Jul 04; 109(1):23-9. PubMed ID: 21223512
    [Abstract] [Full Text] [Related]

  • 20. Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides.
    Matsui H, Okumura K, Kawakami K, Hibino M, Toki Y, Ito T.
    Diabetes; 1997 Mar 04; 46(3):348-53. PubMed ID: 9032088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.